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Summary
Background: Vitamin D is important for bone health. An
inadequate supply of vitamin D to the body is associated
with a higher fracture risk in the elderly. Young adults with
type 1 diabetes are reported to have a lower peak bone mass
than healthy individuals, which could possibly lead to an
increased fracture risk in the future. The prevalence of vit-
amin D deficiency in healthy young people is high. Thus,
optimal supply of vitamin D may be of particular import-
ance for bone health in children with type 1 diabetes.
Methods: In this prospective cross-sectional study we
measured serum 25-hydroxy-vitamin D, iPTH, total and
ionised calcium, phosphate, and alkaline phosphatase in
129 Swiss children and adolescents with type 1 diabetes.
Results: Of the 129 subjects 78 (60.5%) were vitamin
D deficient, defined as a 25-hydroxy-vitamin-D level be-
low 50 nmol/L. During the winter this number rose to
84.1%. 25-hydroxy-vitamin-D levels showed marked sea-
sonal fluctuations, whereas there was no correlation with
diabetes control. Despite the high prevalence of vitamin D
deficiency, we found a low prevalence of secondary hyper-
parathyroidism in vitamin D deficient diabetic children and
adolescents.
Conclusions: Prevalence of vitamin D deficiency in
diabetic children and adolescents is high. Therefore,
screening for vitamin D deficiency and supplementation in
children with low vitamin D levels may be considered.
Key words: vitamin D deficiency; type 1 diabetes,
parathyroid hormone; 25-OH-cholecalciferol
Introduction
Vitamin D has a major impact on bone health. Severe vit-
amin D deficiency is associated with rickets in the grow-
ing skeleton [1] and osteomalacia in adults [2]. In addition,
low serum vitamin D levels are associated with a higher
fracture risk in elderly people [3]. Furthermore, vitamin D
deficiency is common in healthy children at a variety of
different latitudes [4–18] and in children with type 1 dia-
betes mellitus (T1D), in whom the highly variable preval-
ence ranges between 15–65% at the end of winter [19–21].
Body vitamin D stores in an individual are assessed
by measuring serum 25-hydroxy-vitamin D (25D) levels.
However, there is no consensus on the 25D levels that
are to be considered sufficient in children. The American
Academy of Pediatrics (AAP) has defined vitamin defi-
ciency as serum 25D below 27.5 nmol/L [22]. In infants
and children, however, rickets is already seen at 25D levels
below 37.5 nmol/L [8, 23]. In adolescents 25D levels be-
low 40 nmol/L are associated with unphysiologically high
intact parathyroid hormone (iPTH) levels and low mean
forearm bone mineral density [17]. In adults the use of
biomarkers such as serum PTH concentration or intestinal
calcium absorption rate has recently been recommended
to define biologically relevant circulating 25D levels [1].
This recommendation is based on the observation that both
the intestinal calcium absorption rate increases signific-
antly with rising 25D concentrations until a concentration
of 75 nmol/L is reached and PTH levels also start to in-
crease even at 25D concentrations below 75 nmol/L [24,
25]. Furthermore, 25D concentrations above 75 nmol/L ap-
pear to be important for optimal bone health, prevention
of colorectal cancer and other health issues [1, 26, 27].
Hence, as stated, a 25D cut-off value of above 75 nmol/L
for vitamin D sufficiency and a 25D cut-off value below 50
nmol/L for vitamin D deficiency were adopted in our study
[1, 20, 25].
Clinical studies show that adolescents with T1D have
a lower bone mass compared to their peers [28]. Similarly,
adults with T1D are found to be at higher risk of osteo-
porosis and at higher risk of osteoporosis-related fractures
[28].
In addition, some studies suggest a blunted response
of the PTH to low levels of vitamin D in diabetic patients
further deregulating calcium homeostasis [29–31]. There-
fore, children with both conditions, T1D and vitamin D de-
ficiency, may have an increased risk of bone fragility. Inad-
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equate levels of PTH for a given low serum calcium value
could be an aggravating factor in this setting.
The purpose of this study was to assess the prevalence
of vitamin D deficiency in patients with T1D and to define
factors such as duration of diabetes, HbA1c, age, body mass
index and seasonality which may possibly influence serum
vitamin D levels. Additionally, we determined serum iPTH
concentrations to assess secondary hyperparathyroidism in
patients with vitamin D deficiency. For this purpose we
conducted a prospective, cross-sectional study in children
and adolescents with T1D seen at our outpatient clinic in
Bern, Switzerland.
Subjects and methods
Study subjects
This study was approved by the institutional review board
of the Inselspital at the University of Bern. The participants
in this cross-sectional study were enrolled at the time of
their regularly scheduled annual visit to our outpatient clin-
ic. At study start, 130 patients with T1D previously dia-
gnosed according to the diagnostic criteria of the American
Diabetes Association [32] were examined at our outpatient
clinic. All 130 patients agreed to participate and were thus
included in the study. One patient was excluded from fur-
ther analysis because of hyperparathyroidism (215 pg/ml)
not explained by low vitamin D levels. We categorised each
participant’s study visit according to seasons as follows:
Winter (22 December- 21 March), spring (22 March – 21
June), summer (22 June – 22 September) and autumn (23
September – 21 December). 44 participants were examined
in winter, 20 in spring, 34 in summer and 31 in autumn.
A nutritional questionnaire enquiring into daily con-
sumption of dairy products and calcium-rich mineral water
was used to assess daily calcium intake (see appendix for
details). All participants underwent a general physical ex-
amination. Standard auxological assessment was per-
formed [33]. Measurements of weight were obtained to
the nearest 0.1 kg using a Seca scale (Seca GmbH, Ham-
burg, Germany) and measurements of height were obtained
to the nearest 0.1 cm using an Ulmer Stadiometer (Busse
design, Ulm, Germany). Body mass index (BMI) was cal-
culated as weight (kilograms) divided by height squared
(square meters) [34].
Eight patients were excluded from evaluation of the
PTH – vitamin D axis because measurements of ionised
calcium concentration were not available for technical
reasons.
Laboratory findings
Serum 25D was determined using a competitive chemilu-
minescence immunoassay (DPC Immulite 2500, Liaison,
DiaSorin Inc., Minneapolis, USA). The between run CV
was 8.4%. 25D levels below 50 nmol/L were defined as
vitamin D deficient [1], 25D levels between 50 and 75
nmol/L were defined as vitamin D insufficient and 25D
levels above 75 nmol/L were defined as vitamin D suf-
ficient. Serum intact PTH (iPTH) was determined using
an electro-chemiluminescent immune assay (Roche Mod-
ular E170, Roche Diagnostics Corp., Indianapolis, USA).
The reference values for iPTH were 9–59 pg/ml (6–9.9
years), 11–74 pg/ml (10–13.9 years), 9–69 pg/ml (14–17.9
years) and 10–65 pg/ml (adults). Serum ionised calcium
was measured at a pH of 7.40 and 37 °C using an ion-se-
lective electrode (Radiometer ABL800, Radiometer Gm-
bH, Thalwil, Switzerland). Serum alkaline phosphatase
was determined by a standard colorimetric assay on a
Roche Modular P800 (Roche Diagnostics Corp.). HbA1c
was assessed using a latex immunoagglutination method
standardised to the DCCT assay with a reference range of
4.5–5.6% (DCA 2000+, Siemens Co. Dublin, Ireland).
Statistical analysis
Results are expressed as mean ± 95% confidence interval
(95% CI) unless otherwise stated. Statistical analysis was
performed using the SPSS 17 (www.spss.com) statistics
program. For detailed analysis, participants were divided
into three groups according to their 25-OHD levels: >75
nmol/L: vitamin D sufficient, 50–75 nmol/L: vitamin D in-
sufficient, <50 nmol/L: vitamin D deficient. Differences
between groups were analysed by one-way ANOVA. Cross
tabulation analysis with χ2 – test was performed for ana-
lysis of frequencies and the results plotted in a 3x4 con-
tingency table. Adjusted residuals were calculated to show
which cell was over- or underrepresented.
Results
We assessed clinical and laboratory findings in 129 chil-
dren and adolescents with T1D. None of the participants
had bone deformities or a history of low intensity trauma
fractures. 69 participants (53.5%) were males 60 (46.5%)
were females. Most of the participants were white (123;
95.3%), the remaining being Indian (4; 3.1%), East-Asian
(1; 0.8%) and black (1; 0.8%). The characteristics of the
whole group and those of the three subgroups related to
vitamin D levels are shown in table 1. No statistically sig-
nificant differences in patients’ characteristics between the
Figure 1
Alkaline phosphatase (mean±95% confidence intervals) according
to 25-OH-D levels
One-way-ANOVA showed significant difference between the means
(p = 0.03). The graph shows that alkaline phosphatase was
significantly lower in participants with 25-OH-D levels above 75
nmol/L.
Original article Swiss Med Wkly. 2010;140:w13091
Swiss Medical Weekly · PDF of the online version · www.smw.ch Page 2 of 6
three subgroups were found by one-way ANOVA. 87% (n:
112) of the patients with T1D had 25D levels below 75
nmol/L, whereas 60.5% (n:78) were vitamin D deficient
with 25D levels below 50 nmol/L. Calcium intake and the
results of calcium and phosphate metabolism are shown
in table 2. The only variable showing statistically signific-
ant differences between the three subgroups as tested by
one-way-ANOVA was alkaline phosphatase (F = 3.592, p
= 0.03). A plot for means with 95% confidence shows that
alkaline phosphatase in both vitamin D deficient and vit-
amin D insufficient groups was significantly higher than in
the vitamin D sufficient (fig. 1). It is important to stress that
neither calcium intake, age, duration of diabetes, HbA1c
nor serum magnesium concentration did explain any of the
variance of serum 25D levels.
Cross tabulation revealed a highly significant effect of
season on the levels of 25D (χ2 = 38.9, p <0.001). 98%
of patients seen during the winter period, 90% of patients
seen during spring, and 90% of patients seen in the autumn
presented with 25D levels below 75 nmol/L (table 3). By
contrast, only 68% of patients seen in the summer presen-
ted with 25D levels below 75 nmol/L. Analysis of adjus-
ted residuals showed that during winter and spring there
were relatively more vitamin D deficient patients than in
the yearly average, whereas in autumn the number of vit-
amin D deficient, insufficient and sufficient patients corres-
ponded approximately to the yearly average. Furthermore,
only during the months of July, August and September did
more than 75% of the patients show 25D levels of above 50
nmol/L (fig. 2).
We found that iPTH was similar in all three subgroups
(table 2). Three (3.8%) patients with vitamin D levels <50
nmol/l had hyperparathyroidism defined as iPTH above +2
SD for age. Eight patients (26%) with very low 25D levels
(<25 nmol/L) were found to have iPTH levels above 50 pg/
ml but only two were elevated above 2 SD for age qualify-
ing for a diagnosis of secondary hyperparathyroidism.
Discussion
Our participants with T1D were found to have a high pre-
valence of vitamin D deficiency. Vitamin D levels showed
a marked seasonal fluctuation. Additionally, vitamin D de-
ficient children and adolescents with T1D have a low pre-
valence of secondary hyperparathyroidism.
It is of importance to state that the sample size is rep-
resentative for a number of children and adolescents suffer-
ing from T1D in the area: the Canton of Bern has a popu-
lation of 962 982. Considering the registered incidence of
T1D in children and adolescents of 15/100 000 per year in
Table 1
Patient characteristics.
Total (n = 129) Vitamin D sufficient (n = 17)
25-OH-D >75 nmol/L
Vitamin D insufficient (n = 34)
25-OH-D 50–75 nmol/L
Vitamin D deficient (n = 78)
25-OH-D <50 nmol/L
Mean 95% CI Mean 95% CI Mean 95% CI Mean 95% CI
Age, years 11.6 11.0–12.3 12.5 10.5–14.5 10.9 9.6–12.2 11.7 10.8–12.6
Weight-SDS 0.13 –0.02–0.28 –0.04 –0.6–0.53 0.23 –0.02–0.48 0.12 –0.07–0.32
Height-SDS 0.06 –0.11–0.22 –0.10 –0.57–0.38 –0.02 –0.34–0.34 0.12 –0.1–0.33
BMI-SDS 0.14 0.0–0.29 –0.02 –0.47–0.43 0.31 0.06–0.56 0.11 –0.09–0.3
Duration of diabetes, years 4.9 4.3–5.5 5.8 4.0–7.7 4.0 3.0–4.9 5.1 4.3–6.6
HbA1c % 8.1 7.9–8.4 8.1 7.7–8.6 7.9 7.7–8.2 8.2 7.9–8.6
Table 2
Results.
Total (n = 129) Vitamin D sufficient (n = 17)
25-OH-D >75 nmol/L
Vitamin D insufficient (n = 34)
25-OH-D 50-75 nmol/L
Vitamin D deficient (n = 78)
25-OH-D <50 nmol/L
Mean 95% CI Mean 95% CI Mean 95% CI Mean 95% CI
Calcium intake, mg/d1 845.3 760.6–930.0 822.4 672.6–972.1 920.9 738.1–1103.6 818.0 704.3–931.7
Calcium, mmol/L 2.36 2.34–2.37 2.35 2.31–2.38 2.37 2.34–2.4 2.35 2.34–2.37
Ca2+, mmol/L 1.22 1.22–1.23 1.22 1.21–1.23 1.24 1.22–1.25 1.22 1.21–1.23
Phosphate, mmol/L 1.41 1.38–1.44 1.41 1.34–1.49 1.38 1.31–1.44 1.43 1.38–1.47
Magnesium, mmol/L 0.81 0.80–0.82 0.80 0.78–0.83 0.81 0.79–0.82 0.82 0.80–0.83
Alk. Phosphatase U/l 223 208–239 171 132–211 236 209–263 230 208–250
iPTH, pg/ml2 35.8 33.3–38.3 34.8 29.2–40.5 31.4 28.3–34.4 38.0 34.3–41.6
25-OH-D, nmol/L 45.7 41.2–50.3 92.5 83.4–101.5 61.3 58.6–63.9 28.8 26.0–31.6
1 Calcium intake according to food frequency questionnaire
2 only iPTH results of 121 participants were available (vitamin D sufficient n = 16, vitamin D insufficient n = 32, vitamin D deficient n = 73).
Table 3
Frequency of Vitamin D deficiency and insufficiency by season.
Winter Spring Summer Autumn Total
N (%) 37 (84) 16 (80) 7 (21) 18 (58) 78 (61)Vitamin D deficient
(25-OH-D >75 nmol/L) adjusted residual 3.9 1.9 –5.5 –0.3
N (%) 6 (14) 2 (10) 16 (47) 10 (32) 34 (26)Vitamin D insufficient
(25-OH-D 50-75 nmol/L) adjusted residual –2.4 –1.8 3.2 0.9
N (%) 1 (2) 2 (10) 11 (32) 3 (10) 17 (13)Vitamin D sufficient
(25-OH-D <50 nmol/L) adjusted residual –2.6 –0.5 3.9 –0.7
Chi-square-test: χ2 = 38.9 (6 df), p <0.001
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2008 (data of the ongoing incidence study in Switzerland,
personal communication: Prof. Eugen J. Schoenle, Zürich)
we estimated a total of about 280 children between the ages
of 0–16 years with T1D living in the Canton of Bern. We
could therefore conclude that approximately 50% of the
children with T1D living in the Canton of Bern participated
in this study.
A most important finding is that the prevalence of vit-
amin D deficiency was higher in our cohort (60.5%) than
in previous studies analysing subjects with T1D (15–43%)
using the same cut-off values to define serum vitamin D
status. The prevalence of vitamin D deficiency was 43%
in an Australian study [19], about 25% in an Italian study
[21] and 15% in a recent study in US East Coast youth
[20]. However, when focusing on the prevalence of vitamin
D sufficiency, the data were similar: Bern: 13%; Australia:
19%; US East coast: 25%. Thus the main difference is in
the range of insufficiency (26–36%) [19–21]. These over-
all differences might be explained by the variability of geo-
graphical environment, the age of the subjects, duration of
diabetes (diagnosis vs. follow-up), glycaemic control etc.
as recently suggested [20]. In contrast, 25D levels were
usually above 50 nmol/L in young adults at diagnosis of
T1D in Sweden [35].
It is not surprising to find a marked seasonal variability
of 25D levels since UV light exposure is essential for
vitamin D biosynthesis in the skin [36]. Only during the
months of July, August and September were 25D levels
sufficient for most patients. This is in line with the Swedish
study showing similar month-to-month fluctuations of the
25D levels although at a higher concentration [35]. In T1D
children of the US East Coast vitamin D deficiency was
found in 47% during winter and in only 5% during summer
[20]. One might argue that the much higher prevalence of
vitamin D deficiency found even during the summer in our
study is due to absence of vitamin D supplementation in
Figure 2
Boxplot of 25-OH-D by month of consultation
Circles indicate outliers (one and a half to three box-lengths outside
the box), asterisks indicate extreme values (more than three box-
lengths outside the box). The top line indicates the cut-off for
vitamin D insufficiency (75 nmol/L), the bottom line indicates the
cut-off for vitamin D deficiency (50 nmol/L). January corresponds to
month 1, December to month 12.
many Swiss foods compared to other countries such as the
US. Also, outdoor activities may play a key role when com-
paring other studies with Swiss data.
An additional finding was that the prevalence of sec-
ondary hyperparathyroidism was very low in vitamin D de-
ficient patients. In contrast, PTH levels never fell below 20
pg/ml in our patients, which is clearly above the level of 10
pg/ml expected for the continuous tonic secretion of PTH
[12, 37], which suggests that the continuous tonic PTH se-
cretion might be elevated in diabetic subjects. In adults,
PTH levels are expected to rise steeply above 40 pg/ml at
25D levels below 50 nmol/L and above 50 pg/ml at 25 D
levels below 25 nmol/L [27]. This relationship seems to be
less pronounced in healthy adolescents [12]. We have two
possible explanations why PTH levels did not show the ex-
pected rise in diabetic children and adolescents. First, the
PTH-vitamin D axis has a blunted response in diabetic pa-
tients, a finding supported by several studies [29, 31]. In
one study a blunted response of PTH was associated with
low magnesium levels and corrected after magnesium re-
pletion [30]. Our patients, however, did not show any mag-
nesium depletion. A blunted response of PTH would result
in inadequately normal PTH levels with low ionised calci-
um. However, we did not find differences in ionised calci-
um levels between vitamin D deficient and vitamin D suf-
ficient patients. Furthermore, the participants in our study
had a mean calcium intake of 845 mg/day, close to the
recommended daily intake for age of 1200 mg/day [38].
Since it is known that the clinical signs of vitamin D defi-
ciency (rickets, hyperparathyroidism) are highly dependent
on calcium intake [39], one can speculate that in our pa-
tients lacking PTH rise even in severely vitamin D insuffi-
cient individuals was due to near optimal oral calcium in-
take. However, no calcium balance studies were performed
to investigate this hypothesis any further. In addition, in-
creased tonic PTH secretion could have a protective ef-
fect on serum calcium concentrations. Second, hypocal-
caemia was too mild to induce a rise in PTH in our patients.
Physiologically the set-point in the inverse sigmoidal rela-
tionship between ionised calcium and PTH is around 1.22
mmol/L and PTH secretion reaches a plateau at ionised cal-
cium concentrations below 1.15 mmol/L [37]. The concen-
tration of ionised calcium in our patients, however, was
mostly above 1.2 mmol/L and only three patients had val-
ues below 1.15 mmol/L. Hence, in our cohort we have not
enough data to define both a top and bottom plateau of the
sigmoidal relationship between iPTH and ionised calcium
for a detailed description in comparison to a normal curve.
A clear limitation of our study is that no control group
of non-diabetic children was included. However, similar
studies in healthy children showed a prevalence of vitamin
D deficiency in the same range (4-7, 10–12, 15–17, 40, 41).
In the only existing Swiss study 15% of the participants
aged between 11-16 years (29% if only adolescents of Tan-
ner stage 4 and 5 were considered) had 25-OH levels be-
low 30 nmol/L compared to 36% in our study [42]. Fur-
thermore, a recent study in healthy German children and
adolescents (who are in terms of customs and genetic back-
ground the closest to our study population) showed sim-
ilar results, with 63% of the participants having 25-OH-
D levels below 50 nmol/L [41]. Another limitation of our
Original article Swiss Med Wkly. 2010;140:w13091
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study is that the effective time of sunshine exposure was
not assessed for the individual patient.
In summary, we show that vitamin D deficiency is
highly prevalent in young people with T1D attending our
outpatient clinic, and that there is a marked seasonal fluc-
tuation of serum 25D levels. Additionally, we found a low
prevalence of secondary hyperparathyroidism in vitamin D
deficient subjects. Knowing that vitamin D deficiency af-
fects bone health, these findings raise the question wheth-
er vitamin D deficiency should be screened for and sup-
plementation recommended in children with low levels.
Since 25-OH-D levels above 37.5 nmol/L are necessary to
prevent nutritional rickets, we suggest those children be
treated according to AAP recommendations regardless of
presence or absence of clinical symptoms and signs [43].
To prevent bone disease in adulthood, vitamin D supple-
mentation may be considered even for children and ad-
olescents with 25-OH-D levels between 37.5–75 nmol/L.
Further studies are needed to solve these questions and to
identify mechanisms responsible for the low prevalence of
secondary hyperparathyroidism in T1D subjects with low
vitamin D levels.
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manuscript.
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Appendix
Calcium intake was assessed by asking the participants
how many units of various dairy products they usually
took during a week and by calculating the corresponding
calcium intake by day. The sample units of dairy products
were shown to the participants on a visual scale. Calcium
intake through mineral water or calcium supplements was
calculated separately and the result added to the intake
resulting from dairy products. We based our calculations
of calcium content of dairy products and mineral water on
the following assumptions:
Product Unit Calcium content
Milk 1 dl 120 mg
Joghurt 150 g 215 mg
Cottage cheese 200 g 180 mg
Soft cheese 40 g 20 mg
Medium-hard cheese 40 g 28 mg
Hard cheese 40 g 48 mg
High Ca mineral water (i.e.Valser) 1 dl 55 mg
Medium Ca mineral water (i.e. Aproz) 1 dl 30 mg
Low Ca mineral water (i.e. Evian) 1 dl 10 mg
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